| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.004 | 0.9 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | 0.0094 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |